Genome-wide Association Study of Pituitary Tumors

The recruitment status of this study is unknown because the information has not been verified recently.

Verified September 2011 by Huashan Hospital.
Recruitment status was Recruiting

Sponsor:

Information provided by (Responsible Party):

Zhaoyun Zhang, Huashan Hospital

ClinicalTrials.gov Identifier:

NCT01442220

First received: September 26, 2011

Last updated: September 27, 2011

Last verified: September 2011

History of Changes

Purpose

Pituitary adenomas is a very common disease, but the cause and genetics hasn't been identified. The investigators are going to use genome-wide association study to identify genes that may be related to pituitary adenomas.

Condition
Pituitary Adenomas


Study Type:	Observational
Study Design:	Observational Model: Case Control Time Perspective: Prospective
Official Title:	Genome-wide Association Study of Pituitary Tumors

Resource links provided by NLM:

Genetics Home Reference related topics: familial isolated pituitary adenoma

MedlinePlus related topics: Pituitary Disorders Pituitary Tumors

U.S. FDA Resources

Further study details as provided by Huashan Hospital:

Biospecimen Retention: Samples With DNA

DNA samples


Estimated Enrollment:	12500
Study Start Date:	September 2011
Estimated Study Completion Date:	July 2014
Estimated Primary Completion Date:	June 2013 (Final data collection date for primary outcome measure)

Eligibility


Ages Eligible for Study:	Child, Adult, Senior
Genders Eligible for Study:	Both
Accepts Healthy Volunteers:	Yes
Sampling Method:	Non-Probability Sample

Study Population

Patients diagnosed with pituitary adenomas and healthy controls will be included.

Criteria

Inclusion Criteria:

patients diagnosed with pituitary adenomas

Exclusion Criteria:

patients with a family history of endocrine tumors

Contacts and Locations

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01442220

Contacts


Contact: Yao Zhang, Dr.	86-13916872553	zhaoyaohs@vip.sina.com

Locations


China, Shanghai
Huashan Hospital	Recruiting
Shanghai, Shanghai, China, 200040
Contact: Yao Zhao 86-13916872553 zhaoyaohs@vip.sina.com
Principal Investigator: Yao Zhao

Sponsors and Collaborators

Huashan Hospital

Investigators


Principal Investigator:	Yao Zhao, M.D.	Huashan Hospital

More Information


Responsible Party:	Zhaoyun Zhang, Doctor, Huashan Hospital
ClinicalTrials.gov Identifier:	NCT01442220 History of Changes
Other Study ID Numbers:	KY2011-277
Study First Received:	September 26, 2011
Last Updated:	September 27, 2011
Health Authority:	China: Food and Drug Administration

Additional relevant MeSH terms:


Pituitary Neoplasms Pituitary Diseases Adenoma Hypothalamic Diseases Brain Diseases Central Nervous System Diseases Nervous System Diseases Endocrine System Diseases Neoplasms, Glandular and Epithelial	Neoplasms by Histologic Type Neoplasms Endocrine Gland Neoplasms Neoplasms by Site Hypothalamic Neoplasms Supratentorial Neoplasms Brain Neoplasms Central Nervous System Neoplasms Nervous System Neoplasms

ClinicalTrials.gov processed this record on September 29, 2016

To Top